Cancer Radiothérapie : Journal De La Société Française De Radiothérapie Oncologique
Overview
Cancer Radiothérapie : Journal De La Société Française De Radiothérapie Oncologique is a scientific journal, published by Elsevier since 1997 in French. The journal's country of origin is France and its primary focus area is oncology.
Details
Details
Metrics
Metrics
h-index / Ranks: 9376
36
SJR / Ranks: 10302
405
CiteScore / Ranks: 10891
1.90
JIF / Ranks: 6403
1.3
Recent Articles
11.
Mignot F, Bruna A, Msika R, Legrand-Hamon C, Monpetit E, Bleichner O
Cancer Radiother
. 2024 Nov;
28(8):699-702.
PMID: 39581826
Private radiotherapy centres treat almost one in two patients in France. However, very few of these centres perform uterovaginal brachytherapy. In this short communication, we look at the reasons for...
12.
El Ayachi Z, Gabro A, Camprodon G, Chopra S, Maingon P, Chargari C
Cancer Radiother
. 2024 Nov;
28(8):719-726.
PMID: 39580331
The field of gynaecologic oncology has evolved rapidly in recent years, largely driven by advances in both radiotherapy and systemic therapies. These innovations have reshaped the management of key gynaecologic...
13.
Agnoux E, Stefani A, Sahki N, Meknaci E, Jolnerovski M
Cancer Radiother
. 2024 Nov;
28(8):677-685.
PMID: 39578140
Purpose: Extremity soft-tissue sarcomas are treated by wide surgical resection with normofractionated radiotherapy. Over the past 3years, several phase II trials emerged on perioperative hypofractionated radiotherapy. We aimed to review...
14.
Rakotosamimanana M, Renard-Oldrini S, Sahki N, Faivre J
Cancer Radiother
. 2024 Nov;
28(8):693-698.
PMID: 39578139
Purpose Of The Study: The purpose of the study was to evaluate retrospectively the acute toxicity and efficacy in terms of locoregional control of a cervical lymph node irradiation using...
15.
Badiei Moghaddam S, Rakhsha A, Siavashpour Z
Cancer Radiother
. 2024 Nov;
28(8):650-656.
PMID: 39578138
Purpose: Alopecia is a distressing side effect of radiotherapy in patients undergoing treatment for primary brain tumours. This study aimed to investigate the most influential clinical, demographic, and dosimetric factors...
16.
Brassart C, Coutte A, Wallet J, Meyer E, Benyoucef A, Mnif H, et al.
Cancer Radiother
. 2024 Nov;
28(8):657-666.
PMID: 39578137
Purpose: Trimodal therapy, an organ-sparing alternative, may be proposed for selected patients with muscle-invasive bladder cancer instead of radical cystectomy. In this multicentre retrospective study, we aimed to assess the...
17.
Bennassi A, Cherif M, Debbi K, Belkacemi Y
Cancer Radiother
. 2024 Nov;
28(8):703-706.
PMID: 39572358
No abstract available.
18.
Mione C, Saroul N, Casile M, Moreau J, Miroir J, Molnar I, et al.
Cancer Radiother
. 2024 Nov;
28(8):667-676.
PMID: 39537465
Purpose: Intensity-modulated radiation therapy or volumetric-modulated arctherapy is nowadays the recommended radiation technique for the treatment of head and neck cancers. However, by providing a significant dose gradient between target...
19.
Le Guevelou J, Houssayni A, Key S, Largent A, Lafond C, Acosta O, et al.
Cancer Radiother
. 2024 Nov;
28(8):686-692.
PMID: 39516122
Purpose: The purpose of the study was to evaluate the dosimetric impact of sexual-sparing radiotherapy for prostate cancer, with magnetic resonance-only treatment planning. Material And Methods: Fifteen consecutive patients receiving...
20.
Jan L, Labreuche J, Liem X, Rysman B, Morisse M, Mortuaire G, et al.
Cancer Radiother
. 2024 Oct;
28(8):727.
PMID: 39477747
No abstract available.